Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
- Conditions
- Benign Prostatic HyperplasiaEnlarged Prostate
- Registration Number
- NCT00435448
- Lead Sponsor
- Threshold Pharmaceuticals
- Brief Summary
The purpose of this study is to evaluate the efficacy of lonidamine (50mg, 150mg) compared to placebo in subjects with symptomatic BPH.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Male
- Target Recruitment
- 480
- Capable of understanding the purpose and risks of the study and sign a statement of informed consent
- Male 50-80 years of age
- Presence of LUTS (lower urinary tract symptoms) for at least 3 months
- Prostate volume measured by TRUS (transrectal ultrasound) > 30 cc
- Qmax < 15 mL/sec when measured by uroflowmetry (minimum of 125 mL must be voided)
- I-PSS (International prostate symptom score) > 12
- PSA > 1.0 ng/mL
- Must ensure and consent to use medically acceptable methods of contraception throughout the entire study with sexual partners of childbearing potential
- Able to comply with the prescribed treatment protocol and evaluations
-
Prior treatment for BPH with alpha-blockers and/or herbal supplements in the past 2 weeks (alpha-blockers and herbal supplements for the treatment of BPH are not allowed during the study). Prior treatment with 5-alpha-reductase inhibitors is allowed if discontinued at least 3 months prior to enrollment.
-
Prior surgery of the prostate (except biopsies; subject is eligible to enroll one month after full recovery from prostate biopsy.)
-
Current or past evidence of malignant disease of the prostate or prostatic intraepithelial neoplasia (for subjects with PSA between 4 - 10 ng/mL, prostate cancer must be ruled out to the satisfaction of the Principal Investigator. Subjects with PSA >10 ng/mL are excluded.)
-
Active urinary tract infections (UTI)
-
Active cardiac, renal or hepatic disease as evidenced by:
- Serum creatinine > 1.8 mg/dL
- ALT or AST > 2.5x the upper limit of normal at screen
- History of active myocardial infarction,unstable cardiac arrhythmias or stroke within 6 months prior to screening
- Uncontrolled congestive heart failure
-
Uncontrolled diabetes mellitus (fasting blood glucose > 200 mg/dL)
-
Use of systemic teriods for any reason (systemic steroid usage is not allowed during the study). Inhaled and/or topical steroids are allowed.
-
Concurrent participation or participation in an investigational drug study within the past 30 days prior to screening
-
Concomitant disease or condition that could interfere with the conduct of the study, or would in the opinion of the investigator,pose an unnaceptabele risk to the subject
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
Name Time Method International prostate symptom score (I-PSS)
- Secondary Outcome Measures
Name Time Method Qmax on uroflowmetry Post micturitional residue Volume of the prostate PSA
Trial Locations
- Locations (58)
Wojewódzki Szpital,Oddział i Poradnia Urologiczna
🇵🇱Legnica, Poland
Dombóvári Szt. Lukács Egészségügyi Közhasznú
🇭🇺Dombóvár, Hungary
Petz Aladár County Hospital
🇭🇺Gyor, Hungary
Semmelweis University
🇭🇺Budapest, Hungary
Fővárosi Önkormányzat Jahn Ferenc Dél-Pesti Kórház
🇭🇺Budapest, Hungary
Kaposi Mór County Hospital
🇭🇺Kaposvar, Hungary
Nagykanizsa Megyei Jogú Város Hospital
🇭🇺Nagykanizsa, Hungary
Gróf Esterházy Kórház
🇭🇺Papa, Hungary
Dr. Bugyi István Hospital
🇭🇺Szentes, Hungary
Saint Bobála Hospital
🇭🇺Tatabánya, Hungary
Wojewódzki Szpital Specjalistyczny im. Janusza Korczaka, Oddział Urologii
🇵🇱Slupsk, Poland
Szpital Specjalistyczny, Oddział Urologii
🇵🇱Wejherowo, Poland
Urologische Klinik und Poliklinik der Technischen Universität München, Klinikum Rechts der Isar
🇩🇪München, Germany
Károlyi Sándor Hospital
🇭🇺Budapest, Hungary
Universitätsklinik Köln, Klinik und Poliklinik für Urologie
🇩🇪Köln, Germany
ClinPharm International GmbH & Co KG--Dresden
🇩🇪Dresden, Germany
Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Urologie und Kinderurologie
🇩🇪Kiel, Germany
ClinPharm International GmbH & Co KG--Magdeburg
🇩🇪Magdeburg, Germany
Ospedale S.Annunziata, Unità Operativa di Urologia
🇮🇹Firenze, Italy
Urologische Universitätsklinik, Klinikum Mannheim gGmbH, Fakultät für Klinische Medizin Mannheim
🇩🇪Mannheim, Germany
Klinikum der Universität München, Urologische Klinik und Poliklinik
🇩🇪München, Germany
Klinik für Urologie und Kinderurologie, Klinikum Marburg
🇩🇪Marburg, Germany
ClinPharm International GmbH & Co KG--Chemnitz
🇩🇪Chemnitz, Germany
Gemeinschaftspraxis Jacobi - Hellmis
🇩🇪Duisburg, Germany
ClinPharm International GmbH & Co KG--Leipzig
🇩🇪Leipzig, Germany
A.O. Policlinico di Bari, Clinica Urologica
🇮🇹Bari, Italy
Azienda Ospedaliera, Dipartimento di Urologia
🇮🇹Padova, Italy
ClinPharm International GmbH & Co KG--Frankfurt/Main
🇩🇪Frankfurt, Germany
Klinik für Urologie, Eberhard-Karls-Universität Tübingen
🇩🇪Tubingen, Germany
Vivantes Klinikum am Urban, Klinik für Urologie
🇩🇪Berlin, Germany
Clinic of Urology
🇭🇺Debrecen, Hungary
Wuppertaler Gemeinschaftspraxis für Dermatologie, Gynäkologie und Urologie
🇩🇪Wuppertal, Germany
Wojewódzki Szpital Specjalistyczny nr 4
🇵🇱Bytom, Poland
"Specjalista" Spółka z o. o.
🇵🇱Kutno, Poland
Szpital Specjalistyczny Oddzial Urologii
🇵🇱Koscierzyna, Poland
Specjalistyczna Praktyka Lekarska
🇵🇱Katowice, Poland
Katedra i Klinika Urologii Pomorskiej Akademii Medycznej
🇵🇱Szczecin, Poland
Katedra i Klinika Urologii AM we Wrocławiu
🇵🇱Wroclaw, Poland
A.O. Policlinico di Bari, Clinica Urologica I
🇮🇹Bari, Italy
Università di Genova Ospedale S. Martino, Reparto Urologia
🇮🇹Genova, Italy
Azienda Ospedaliera S.Luigi di Orbassano, Reparto di urologia universitaria
🇮🇹Orbassano, Italy
A.O. Pliclinico Paolo Giaccone, U.O. Urologia con Litotrissia Extracorporea
🇮🇹Palermo, Italy
Azienda Ospedaliera Pisana, Dipartimento di Urologia 1
🇮🇹Pisa, Italy
Ospedale Maggiore S.Giovanni Battista, Istituto di Urologia
🇮🇹Torino, Italy
Urologische Klinik, Klinikum Landkreis Neumarkt i.d.Obf.
🇩🇪Neumarkt, Germany
Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Urologie
🇩🇪Hamburg, Germany
niversitätsklinikum Carl Gustav Carus, Klinik und Poliklinik für Urologie
🇩🇪Dresden, Germany
ClinPharm International GmbH & Co KG--Gorlitz
🇩🇪Gorlitz, Germany
Policlinico Sassarese, Istituto di Clinica Urologica
🇮🇹Sassari, Italy
Klinika Urologii AM w Białymstoku
🇵🇱Bialystok, Poland
Ospedale S.Paolo, Cattedra di Urologia
🇮🇹Milano, Italy
Università Federico II, Clinica Urologica Edificio 5
🇮🇹Napoli, Italy
Ospedale S.Giovanni Bosco, Dipartimento di Urologia
🇮🇹Torino, Italy
Gabinet Urologiczny
🇵🇱Gdańsk, Poland
Szpital Im. Kardynała Stefana Wyszyńskiego, Oddział Urologii
🇵🇱Lublin, Poland
Szpital Bielański, Oddział Urologii
🇵🇱Warszawa, Poland
NZOZ Lekarze Urolodzy, Marek Rozniecki i Partnerzy
🇵🇱Łask, Poland
Katedra i Klinika Urologii Śląskiej Akademii Medycznej
🇵🇱Zabrze, Poland